July 28, 2017 5:16pm

 

Opens up, slides at mid-day and closes to the downside

Daily to-and-fro action has a downward tilt contributing to the more investor uncertainty

 

Pre-open indications: 5 hits and 4 miss (all but one by pennies)

 

It’s called premium content for a reason … I define insight  from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!

Others don’t even come close!

 

I answer one question, in which company should investors commit and keep their money.

 

 

Friday’s results have implications to Monday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

 

Henry’omics:

From the pre-open’s investor’s newsletter, “too many potholes as quirky IBB dumps (-1.87%) and VIX jumps (+5.31%) pre-weekend tumble but wait for the big stumble.”

  • Volume was still sluggish and all over the map; which seems higher in selling – again; it is just a gauge of sentiment.

Cell therapy has the potential to saving lives? It’s has been said to be true but, there are issues that contain their development and – many are self-induced!

  • Cell therapy equities are boom and bust – by the day and mostly by the hour!

 

Reiterating, “What needs to change, the value of staying the course is an overworked belief in this world of high-frequency trading, ETF exposure and the summer doldrums.  Admittedly, every cell therapy investing group is more focused on the short term as the average holding period has shrunk from years, months to days or hours — the rewards of patience are declining by the minute.”

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was positive with an A/DL of 23/16 and 4 flats;

·         The mid-day was negative with an A/DL of 19/22 and 2 flats;

·         The close was negative  with an A/DL of 16/25 and 3 flats;

 

 

Pre-open indications: 5 hits and 4 miss

  • Applied Genetic Technologies (AGTC) closed down -$0.05 – miss;
  • bluebird bio (BLUE) closed up +0.85 – miss;
  • Capricor (CAPR) closed down -$0.16 – hit;
  • Cellectis SA (CLLS) closed down -$0.03 – hit;
  • Cesca Therapeutics (KOOL) closed up +$0.41 – hit;
  • International Stem Cell (ISCO) closed down -$0.05 – hit;
  • BioLife Solutions (BLFS) closed up +$0.08 – miss;
  •  Sangamo Therapeutics (SGMO) closed up +$0.10 – miss;
  •  Vericel (VCEL) closed down - $0.10 – hit;

 

 

Daily analytics:

The S&P 500 and NASDAQ both finished slightly lower on Friday, while the Dow finished at a record for a weekly gain.

The S&P 500 index (SPX) wrapped up down 3.32 points, or 0.1%, at 2,472.10, recovering from an earlier 10-point deficit, with eight of its 11 main sectors trading in negative territory. The index finished at a less than 0.1% loss on the week.

The Dow (DJIA) which touched an all-time intraday high, rose 33.76 points, or 0.2%, to close at a record 21,830.31, shaking off an earlier 40-point decline.

The NASDAQ declined 7.51 points, or 0.1%, to close at 6,374.68, after an earlier decline of 45 points. The index finished down 0.2% on the week.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded Friday at 10.29 up +1.78 following Thursday’s +5.31% to 10.11, Wednesday’s 9.60, Tuesday’s near 9.43 – flat as compared to Monday’s 9.43 …

 

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Friday down -0.28%

·         Thursday was down -0.64%

·         Wednesday was down -0.57%

·         Tuesday was up +0.89%

·         Monday’s up +0.14%

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Friday up +0.63%

·         Thursday was down -1.87%

·         Wednesday was up +0.65%

·         Tuesday was down -1.08%

·         Monday’s up +0.76%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %’s migrate……….

·         Friday’s decliners ranged from -0.02% <CYTX> to -12,31% <CAPR> in 25 equities;

·         Thursday’s decliners ranged from -0.45% <OPXA> to -29.15% <CUR> in 31 equities;

·         Wednesday’s decliners ranged from -0.30% <XON> to -12.10% <CUR> in 18 equities;

·         Tuesday’s decliners ranged from -0.10% <JUNO> to -49.64% <CUR> in 29 equities;

·         Monday’s decliners ranged from -0.35% <BSTG> to -56.77% <CYTX> in 18 equities

Versus

………… look at the percentage’s (%) and their decreases …….

·         Friday’s gainers ranged from +0.27%  <XON> to +11.92% <KOOL> in 16 equities;

·         Thursday’s gainers ranged from +0.28%  <FCSC> to +28.71% <CAPR> in 10 equities;

·         Wednesday’s gainers ranged from +0.28%  <VSTM> to +18.85% <ISCO> in 21 equities;

·         Tuesday’s gainers ranged from +0.56%  <XON> to +2.16% <NWBO> in 10 equities;

·         Monday’s gainers ranged from +0.61%  <ATHX> to +10.22% <NWBO> in 20 equities;

 

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  NWBO, CAPR, IMUC, CUR and VCEL

… Upside volume was weighted to:  KOOL, JUNO, MDXG, VSTM and

… Biggest $ downside:  AXGN, BLCM, CAPR, FCSC and ADRO

… Largest $ upside:  KITE, ONCE, BLUE, KOOL and MDXG

… Flat: ATHX, RGNX and ADVM

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.